Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Versuch zur Erhöhung der FEP-Teilnahme

1. Oktober 2026 aktualisiert von: William Smith, University of Pennsylvania

Finanzielle Anreize zur Erhöhung der Behandlungsteilnahme bei der Behandlung von Psychosen in der ersten Episode: Eine nicht randomisierte, adaptive Pilotstudie

Individuals with first-episode psychosis (FEP) are at high-risk for several poor functional and clinical outcomes, including suicide. Coordinated Specialty Care (CSC) is a multidisciplinary, team-based intervention known to improve such outcomes, including suicide risk. However, 30-50% of patients disengage from CSC, thereby limiting its impact. This pilot study will develop and test feasibility of a behavioral change program that uses moderate financial incentives to encourage treatment engagement in 2 CSC programs. A single-arm of 80 patient-participants at these two clinics will be recruited to assess feasibility and acceptability from patient perspectives. Additionally,15 clinicians at these two clinics will be recruited to assess feasibility and acceptability from clinician perspectives, and 50 clinicians from peer clinics not involved in the intervention will be recruited to assess scalability of the intervention. The trial will feature an three-month period for recruitment and baseline data collection and will subsequently feature three intervention periods (3 months each) where modifications to the interventions will be tested (each informed by the feasibility and acceptability findings of the prior period) with the aim of sequentially improving it.

Studienübersicht

Status

Aktiv, nicht rekrutierend

Studientyp

Interventionell

Einschreibung (Geschätzt)

145

Phase

  • Frühphase 1

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • North Carolina
      • Raleigh, North Carolina, Vereinigte Staaten, 27608
        • University of North Carolina at Chapel Hill (ENCOMPASS Program)
    • Pennsylvania
      • Philadelphia, Pennsylvania, Vereinigte Staaten, 19123
        • PEACE Program, Horizon House, Inc.
      • Philadephia, Pennsylvania, Vereinigte Staaten, 19104
        • University of Pennsylvania

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  1. For all participants, age ≥ 18 years old.
  2. For intervention trial and patient feasibility and acceptability measurement: Patients with first-episode psychosis, enrolled in Coordinated Specialty Care at the Psychosis Education, Assessment, Care and Empowerment (PEACE) clinic and Psychosis Evaluation and Recovery Center (PERC).
  3. For clinician feasibility and acceptability measurement at intervention sites: Clinicians working at PEACE and PERC where the intervention will be piloted.
  4. For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: Clinicians in Connection LHS who work at sites other than PEACE and PERC.Participants must sign the informed consent form

Exclusion Criteria:

  1. For intervention trial and patient feasibility and acceptability measurement: Expectation of leaving coordinated specialty care programing within 6 months (which will exclude all of the PI's patient panel) and/or intellectual disability of sufficient degree that the patient's primary psychiatrist expects to compromise capacity to consent to this research and/or psychosis secondary to another medical condition (which may not share the same motivational features that are otherwise understood about the primary psychiatric conditions with psychosis).
  2. For clinician feasibility and acceptability measurement at intervention sites: Study investigators who work at these clinics will be excluded from participation in the feasibility and acceptability study component given their role in the trial planning and execution.
  3. For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: none.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Nicht randomisiert
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Acceptability of intervention measure (AIM)
Zeitfenster: Change at 8 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 8 months
Acceptability of intervention measure (AIM)
Zeitfenster: Change at 6 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 6 months
Acceptability of intervention measure (AIM)
Zeitfenster: Change at 4 months

The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20.

Change at 4 months
Feasibility of intervention measure (FIM)
Zeitfenster: Change at 8 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 8 months
Feasibility of intervention measure (FIM)
Zeitfenster: Change at 6 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 6 months
Feasibility of intervention measure (FIM)
Zeitfenster: Change at 4 months

The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20.

Change at 4 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Implementation Survey Response
Zeitfenster: Change at 8 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 8 months
Implementation Survey Response
Zeitfenster: Change at 6 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 6 months
Implementation Survey Response
Zeitfenster: Change at 4 months

Implementation survey. Results will be used to optimize intervention from implementation perspective.

Change at 4 months
Motivation Survey Response
Zeitfenster: Change at 8 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 8 months
Motivation Survey Response
Zeitfenster: Change at 6 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 6 months
Motivation Survey Response
Zeitfenster: Change at 4 months

Motivation survey. Results will be used to optimize intervention from motivation perspective.

Change at 4 months
Ethical Concern Survey Response
Zeitfenster: Change at 8 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 8 months
Ethical Concern Survey Response
Zeitfenster: Change at 6 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 6 months
Ethical Concern Survey Response
Zeitfenster: Change at 4 months

Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective.

Change at 4 months

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
attrition
Zeitfenster: Change at 8 months

rate of attrition

Change at 8 months
attrition
Zeitfenster: Change at 6 months

rate of attrition

Change at 6 months
attrition
Zeitfenster: Change at 4 months

rate of attrition

Change at 4 months
psychotic symptomology
Zeitfenster: Change at 8 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 8 months
psychotic symptomology
Zeitfenster: Change at 6 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 6 months
psychotic symptomology
Zeitfenster: Change at 4 months

Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology.

Change at 4 months
psychotic symptomology
Zeitfenster: Change at 8 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 8 months
psychotic symptomology
Zeitfenster: Change at 6 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 6 months
psychotic symptomology
Zeitfenster: Change at 4 months

modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology.

Change at 4 months
depression
Zeitfenster: Change at 8 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 8 months
depression
Zeitfenster: Change at 6 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 6 months
depression
Zeitfenster: Change at 4 months

abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology)

Change at 4 months
quality of life
Zeitfenster: Change at 8 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 8 months
quality of life
Zeitfenster: Change at 6 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 6 months
quality of life
Zeitfenster: Change at 4 months

4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life)

Change at 4 months
recovery
Zeitfenster: Change at 8 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 8 months
recovery
Zeitfenster: Change at 6 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 6 months
recovery
Zeitfenster: Change at 4 months

5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery)

Change at 4 months
treatment motivation (intrinsic versus extrinsic)
Zeitfenster: Change at 8 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 8 months
treatment motivation (intrinsic versus extrinsic)
Zeitfenster: Change at 6 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 6 months
treatment motivation (intrinsic versus extrinsic)
Zeitfenster: Change at 4 months

Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5.

Change at 4 months
Perceived coercion
Zeitfenster: Change at 8 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 8 months
Perceived coercion
Zeitfenster: Change at 6 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 6 months
Perceived coercion
Zeitfenster: Change at 4 months

Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others.

Change at 4 months
attendance rate
Zeitfenster: Change over 8 months

number of appointments attended in a given period divided by number of appointments scheduled

Change over 8 months
attendance rate
Zeitfenster: Change at 6 months

number of appointments attended in a given period divided by number of appointments scheduled

Change at 6 months
attendance rate
Zeitfenster: Change at 4 months

number of appointments attended in a given period divided by number of appointments scheduled

Change at 4 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Februar 2025

Primärer Abschluss (Tatsächlich)

18. Dezember 2025

Studienabschluss (Geschätzt)

31. Dezember 2026

Studienanmeldedaten

Zuerst eingereicht

20. Juni 2023

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

28. Juli 2023

Zuerst gepostet (Tatsächlich)

1. August 2023

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

6. Oktober 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

1. Oktober 2026

Zuletzt verifiziert

1. Oktober 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 2023-03

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren